JP2024520802A5 - - Google Patents
Info
- Publication number
- JP2024520802A5 JP2024520802A5 JP2023575818A JP2023575818A JP2024520802A5 JP 2024520802 A5 JP2024520802 A5 JP 2024520802A5 JP 2023575818 A JP2023575818 A JP 2023575818A JP 2023575818 A JP2023575818 A JP 2023575818A JP 2024520802 A5 JP2024520802 A5 JP 2024520802A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence described
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209924P | 2021-06-11 | 2021-06-11 | |
| US63/209,924 | 2021-06-11 | ||
| PCT/US2022/032948 WO2022261398A1 (en) | 2021-06-11 | 2022-06-10 | Antigen recognizing receptors targeting upar and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520802A JP2024520802A (ja) | 2024-05-24 |
| JP2024520802A5 true JP2024520802A5 (enExample) | 2025-06-18 |
Family
ID=84425514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575818A Pending JP2024520802A (ja) | 2021-06-11 | 2022-06-10 | ｕＰＡＲを標的とする抗原認識受容体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240131070A1 (enExample) |
| EP (1) | EP4351601A4 (enExample) |
| JP (1) | JP2024520802A (enExample) |
| CN (1) | CN117715648A (enExample) |
| AU (1) | AU2022287975A1 (enExample) |
| CA (1) | CA3221342A1 (enExample) |
| WO (1) | WO2022261398A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022261403A1 (en) * | 2021-06-11 | 2022-12-15 | Memorial Sloan-Kettering Cancer Center | Antigen recognizing receptors targeting upar and uses thereof |
| EP4610269A1 (en) | 2024-02-29 | 2025-09-03 | 3B Pharmaceuticals GmbH | Urokinase plasminogen activator surface receptor (upar) ligands for diagnostic or therapeutic use |
| WO2026086712A1 (en) * | 2024-10-22 | 2026-04-30 | Peking University | Upar targeting chimeric antigen receptors and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2568428C (en) * | 2004-05-25 | 2020-12-29 | Attenuon, Llc | Ligands binding the complex of urokinase-type plasminogen activator (upa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| CN105368859B (zh) * | 2015-11-25 | 2019-10-18 | 王任直 | 一种嵌合抗原受体hCD87-CAR及载有hCD87-CAR基因结构的慢病毒及质粒及其应用 |
| US20220098320A1 (en) * | 2019-02-01 | 2022-03-31 | Memorial Sloan Kettering Cancer Center | Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarker |
| CN110343665B (zh) * | 2019-05-05 | 2023-07-14 | 吉林大学 | 一种car-t细胞及其应用 |
| WO2022261403A1 (en) * | 2021-06-11 | 2022-12-15 | Memorial Sloan-Kettering Cancer Center | Antigen recognizing receptors targeting upar and uses thereof |
-
2022
- 2022-06-10 CA CA3221342A patent/CA3221342A1/en active Pending
- 2022-06-10 JP JP2023575818A patent/JP2024520802A/ja active Pending
- 2022-06-10 AU AU2022287975A patent/AU2022287975A1/en active Pending
- 2022-06-10 WO PCT/US2022/032948 patent/WO2022261398A1/en not_active Ceased
- 2022-06-10 CN CN202280051494.9A patent/CN117715648A/zh active Pending
- 2022-06-10 EP EP22821083.7A patent/EP4351601A4/en active Pending
-
2023
- 2023-12-11 US US18/535,469 patent/US20240131070A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520803A5 (enExample) | ||
| JP7818838B2 (ja) | 二重特異性抗体およびその適用 | |
| JP7174522B2 (ja) | Ｆｃ受容体様５を標的とするキメラ抗原受容体およびその使用 | |
| US12331114B2 (en) | Humanized anti-CD19 chimeric antigen receptor, its nucleic acid sequence and its preparation | |
| JP2021521275A (ja) | Ｎｋ細胞結合抗体融合構築物 | |
| JP7814759B2 (ja) | 二重特異性組換えタンパク質及びその使用 | |
| WO2019129053A1 (zh) | 以抗体Fc区为骨架的融合蛋白二聚体及其应用 | |
| CN116829194A (zh) | 用于工程化细胞疗法的靶向细胞因子构建体 | |
| JP2020527939A (ja) | タンパク質性ヘテロ二量体及びその用途 | |
| JP2022553464A (ja) | 多重特異性抗体とその製造方法および使用 | |
| JP2022501074A5 (enExample) | ||
| JP2023552851A5 (enExample) | ||
| JP2022521937A5 (enExample) | ||
| JP2024525492A5 (enExample) | ||
| JP2024521472A5 (enExample) | ||
| JP7812549B2 (ja) | 人工免疫監視キメラ抗原受容体（ａｉ－ｃａｒ）及びそれを発現する細胞 | |
| JP2024536840A (ja) | Ｉｌ－２バリアント及びその融合タンパク質 | |
| WO2020172641A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| CN112930195A (zh) | 抗人Fn14抗体 | |
| CN115702163A (zh) | 异二聚体蛋白质 | |
| CA3233085A1 (en) | Composition of recombinant antigen binding molecules and method of making and using thereof | |
| KR20240046224A (ko) | 이중특이성 항체 및 그 용도 | |
| JP2024520803A (ja) | ｕＰＡＲを標的とする抗原認識受容体及びその使用 | |
| JP2024520802A (ja) | ｕＰＡＲを標的とする抗原認識受容体及びその使用 | |
| JP2022513321A5 (enExample) |